Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Guangzhou Jet Biofiltration Co Days Payable?
Guangzhou Jet Biofiltration CoSHSE:688026 +0.74%68 Days Payable is 46.42 as of Mar. 2026, which is 19% below its 10-year median of 57.49. GuruFocus rates SHSE:688026 with a GF Score™ of 68/100 and a GF Value™ of ¥18.12 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 794 Medical Devices & Instruments companies, Guangzhou Jet Biofiltration Co ranks worse than 71.16% on this metric.
The historical rank and industry rank for Guangzhou Jet Biofiltration Co's Days Payable or its related term are showing as below:
SHSE:688026'
s Days Payable Range Over the Past 10 Years
Min: 44.43 Med: 57.49 Max: 66.87
Current: 44.43
During the past 13 years, Guangzhou Jet Biofiltration Co's highest Days Payable was 66.87. The lowest was 44.43. And the median was 57.49.
SHSE:688026's Days Payable is ranked worse than 71.16% of 794
companies
in the Medical Devices & Instruments industry
Industry Median: 67.85
vs SHSE:688026: 44.43
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688026 vs ISRG, BDX, MDLN: Days Payable Comparison
For the Medical Instruments & Supplies subindustry, Guangzhou Jet Biofiltration Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Guangzhou Jet Biofiltration Co Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Guangzhou Jet Biofiltration Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Guangzhou Jet Biofiltration Co's Days Payable falls into.
Guangzhou Jet Biofiltration Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guangzhou Jet Biofiltration Co (SHSE:688026) has a Days Payable of 46.42 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Guangzhou Jet Biofiltration Co and its competitors. This is 19% below median its historical median of 57.49. Over the past decade, Guangzhou Jet Biofiltration Co's Days Payable has ranged from 44.43 to 66.87. According to the industry distribution chart, Guangzhou Jet Biofiltration Co ranks #565 out of 794 companies in the Medical Devices & Instruments industry, placing it in the top 71.2%.
Is Guangzhou Jet Biofiltration Co's Days Payable too high?
Guangzhou Jet Biofiltration Co's current Days Payable of 46.42 is 19% below median its 10-year median of 57.49. Over the past 10 years, this metric has ranged from a low of 44.43 to a high of 66.87. The Medical Devices & Instruments industry median Days Payable is 67.85. Guangzhou Jet Biofiltration Co's value of 46.42 is 31.6% below this industry median. Based on the distribution chart, Guangzhou Jet Biofiltration Co ranks #565 out of 794 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Guangzhou Jet Biofiltration Co has a GF Score™ of 68/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Guangzhou Jet Biofiltration Co's Days Payable compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Guangzhou Jet Biofiltration Co ranks #565 out of 794 companies for Days Payable. This places Guangzhou Jet Biofiltration Co in the lower half of its industry. The industry median Days Payable is 67.85. Guangzhou Jet Biofiltration Co's value of 46.42 is 31.6% below this benchmark. Historically, Guangzhou Jet Biofiltration Co's own Days Payable has ranged from 44.43 to 66.87 over the past decade. While the company's 10-year median is 57.49 vs. the industry median of 67.85, Guangzhou Jet Biofiltration Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.85, based on 794 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Guangzhou Jet Biofiltration Co's current Days Payable of 46.42 is 31.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Guangzhou Jet Biofiltration Co and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Guangzhou Jet Biofiltration Co's current Days Payable is 46.42, which is 19% below median its own 10-year median of 57.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guangzhou Jet Biofiltration Co stock overvalued right now?
Based on GuruFocus' analysis, Guangzhou Jet Biofiltration Co (SHSE:688026) is currently considered Possible Value Trap. The stock's GF Value™ is ¥18.12, compared to a current price of ¥12.20 — trading 32.7% below its estimated fair value. The current Days Payable is 46.42, which is 19% below median its 10-year median of 57.49 and 31.6% below the Medical Devices & Instruments industry median of 67.85. Guangzhou Jet Biofiltration Co's overall GF Score™ is 68/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Guangzhou Jet Biofiltration Co (SHSE:688026), the current Days Payable is 46.42 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Guangzhou Jet Biofiltration Co (SHSE:688026) Overvalued in 2026?
Based on GuruFocus' analysis, Guangzhou Jet Biofiltration Co stock appears to be undervalued.
The current stock price of ¥12.20 is trading 32.7% below its estimated GF Value™ of ¥18.12.
GuruFocus considers Guangzhou Jet Biofiltration Co to be Possible Value Trap.
Key valuation signals for SHSE:688026:
Days Payable: 46.42 (19% below median its 10-year median of 57.49)
GF Value™: ¥18.12 vs. price of ¥12.20 (32.7% below fair value)
Industry Position: 31.6% below the Medical Devices & Instruments median (#565 of 794)
No single metric tells the full story. See the SHSE:688026 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Guangzhou Jet Biofiltration Co Business Description
Guangzhou Jet Biofiltration Co Ltd is engaged in the research and development, manufacturing and sales of laboratory consumable products. Its main products include laboratory consumables (pipettes, tissue culture products, centrifuge tubes, filtration products) analyzer, lab equipment and others.
68GF Score
Get the complete analysis for SHSE:688026
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688026 has been successfully added to your 
